Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC “Principles” Still On PhRMA’s Agenda For 2005

This article was originally published in The Pink Sheet Daily

Executive Summary

The Pharmaceutical Research & Manufacturers of America plans to continue work on voluntary guidelines for direct-to-consumer advertising in 2005

You may also be interested in...



Pfizer Pulling Back “Traditional” DTC Ads, CEO McKinnell Says

The company is moving away from campaigns promoting brand awareness in favor of ads focusing on disease awareness and patient education, the Pfizer exec says. There is a “recognition” in the pharmaceutical industry that direct-to-consumer advertising needs to be reformed, McKinnell notes.

Pfizer Pulling Back “Traditional” DTC Ads, CEO McKinnell Says

The company is moving away from campaigns promoting brand awareness in favor of ads focusing on disease awareness and patient education, the Pfizer exec says. There is a “recognition” in the pharmaceutical industry that direct-to-consumer advertising needs to be reformed, McKinnell notes.

DTC Guidelines Coming Soon From PhRMA

The Pharmaceutical Research & Manufacturers of America is developing guidelines on direct-to-consumer advertising for its members, incoming PhRMA Chairman Miles White (Abbott) said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel